As of 2025-07-20, the Relative Valuation of Kane Biotech Inc (KNE.V) is 0.04 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.05 CAD, the upside of Kane Biotech Inc based on Relative Valuation is -12.4%.
The range of the Relative Valuation is 0.04 - 0.04 CAD.
| Range | Selected | |
| Trailing P/E multiples | 1.0x - 1.1x | 1.0x |
| Forward P/E multiples | 1.0x - 1.1x | 1.0x |
| Fair Price | 0.04 - 0.04 | 0.04 |
| Upside | -14.9% - -9.9% | -12.4% |
| Date | P/E |
| 2025-07-03 | 1.33 |
| 2025-07-02 | 1.46 |
| 2025-06-30 | 1.33 |
| 2025-06-27 | 1.46 |
| 2025-06-26 | 1.33 |
| 2025-06-25 | 1.33 |
| 2025-06-24 | 1.20 |
| 2025-06-23 | 1.33 |
| 2025-06-20 | 1.46 |
| 2025-06-19 | 1.46 |
| 2025-06-18 | 1.46 |
| 2025-06-17 | 1.46 |
| 2025-06-16 | 1.46 |
| 2025-06-13 | 1.60 |
| 2025-06-12 | 1.60 |
| 2025-06-11 | 1.46 |
| 2025-06-10 | 1.46 |
| 2025-06-09 | 1.60 |
| 2025-06-06 | 1.33 |
| 2025-06-05 | 1.73 |
| 2025-06-04 | 1.33 |
| 2025-06-03 | 1.33 |
| 2025-06-02 | 1.46 |
| 2025-05-30 | 1.33 |
| 2025-05-29 | 1.46 |
| 2025-05-28 | 1.46 |
| 2025-05-27 | 1.46 |
| 2025-05-26 | 1.46 |
| 2025-05-23 | 1.46 |
| 2025-05-22 | 1.60 |
| 2025-05-21 | 1.46 |
| 2025-05-20 | 1.60 |
| 2025-05-16 | 1.60 |
| 2025-05-15 | 1.73 |
| 2025-05-14 | 2.00 |
| 2025-05-13 | 2.00 |
| 2025-05-12 | 2.00 |
| 2025-05-09 | 2.13 |
| 2025-05-08 | 2.13 |
| 2025-05-07 | 2.13 |
| 2025-05-06 | 2.13 |
| 2025-05-05 | 2.13 |
| 2025-05-02 | 2.13 |
| 2025-05-01 | 2.13 |
| 2025-04-30 | 2.13 |
| 2025-04-29 | 2.13 |
| 2025-04-25 | 2.53 |
| 2025-04-24 | 2.53 |
| 2025-04-23 | 2.40 |
| 2025-04-22 | 2.53 |